QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.55%)
BABA   74.68 (-2.68%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.71%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+6.86%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)
QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.55%)
BABA   74.68 (-2.68%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.71%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+6.86%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)
QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.55%)
BABA   74.68 (-2.68%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.71%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+6.86%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)
QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.55%)
BABA   74.68 (-2.68%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.71%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+6.86%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)

Burcon NutraScience Stock Price, News & Analysis (TSE:BU)

C$0.14
-0.01 (-6.90%)
(As of 11/29/2023 ET)
Compare
Today's Range
C$0.14
C$0.14
50-Day Range
C$0.10
C$0.16
52-Week Range
C$0.10
C$0.48
Volume
2,575 shs
Average Volume
59,938 shs
Market Capitalization
C$16.42 million
P/E Ratio
N/A
Dividend Yield
4.45%
Price Target
N/A

BU stock logo

About Burcon NutraScience Stock (TSE:BU)

Burcon NutraScience Corporation, together with its subsidiaries, develops plant proteins and ingredients for use in the food and beverage industries in Canada. The company offers Peazazz and Peazac, a pea protein for use in dairy alternatives, ready-to-drink beverages, dry blended beverages, bars, baked goods, and meat substitute products. It provides Puratein, a canola protein isolate for use in meat alternatives, such as burgers, sausages, and nutrition bars; Supertein, a canola protein that is a light-colored powder for use in non-dairy frozen desserts, egg alternative, plant-based marshmallows and ready-to-mix beverages, whipped toppings, and plant-based bars; and Nutratein, a canola protein comprising a mixture of globulin and albumin proteins for use in meat and egg alternatives, and other plant-based functional foods. In addition, the company offers Nutratein-PS, a blend of Peazazz pea protein and Supertein canola protein; Nutratein-TZ, a blend of Peazac pea protein and Puratein canola protein; and CLARISOY, a soy protein for use in sports nutrition beverages, citrus-based drinks, fruit-flavored beverages, lemonades, powdered beverage mixes, and non-beverage plant-based products. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999. The company was incorporated in 1998 and is headquartered in Vancouver, Canada.

BU Stock Price History

BU Stock News Headlines

Burcon NutraScience (TSE:BU) Trading Up 3.6%
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Burcon Reports Fiscal 2024 Second Quarter Results
Burcon NutraScience Corp BU
BU:CA Burcon NutraScience Corporation
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Closing Bell: Burcon Nutrascience Corp flat on Thursday (BU)
Burcon NutraScience Corp (BNE.MU)
Burcon Announces Virtual AGM Details
Burcon Reports Fiscal 2024 First Quarter Results
BRCNF Burcon NutraScience Corp.
See More Headlines
Receive BU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Burcon NutraScience and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
11/29/2023
Next Earnings (Estimated)
2/13/2024

Industry, Sector and Symbol

Industry
Packaged Foods
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
24
Year Founded
N/A

Profitability

Net Income
C$-21,580,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$324,553.00
Cash Flow
C$0.00 per share
Book Value
C$0.03 per share

Miscellaneous

Free Float
N/A
Market Cap
C$17.03 million
Optionable
Not Optionable
Beta
2.40
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Kip Underwood M.B.A.
    Chief Executive Officer
  • Ms. Jade Cheng
    CFO & Treasurer
  • Ms. Kam T. Law (Age 54)
    Senior VP of Legal & Corporate Secretary
    Comp: $208.98k
  • Mr. Randy Willardsen
    Senior Vice President of Process
  • Dr. Martin Hans Schweizer Ph.D.
    Vice President of Technical Development
  • Mr. Paul Lam
    Director of Investor Relations














BU Stock Analysis - Frequently Asked Questions

How have BU shares performed in 2023?

Burcon NutraScience's stock was trading at C$0.39 at the beginning of the year. Since then, BU shares have decreased by 64.9% and is now trading at C$0.14.
View the best growth stocks for 2023 here
.

When is Burcon NutraScience's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 13th 2024.
View our BU earnings forecast
.

What other stocks do shareholders of Burcon NutraScience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Burcon NutraScience investors own include Aytu BioPharma (AYTU), Crescent Point Energy (CPG), Aurora Cannabis (ACB), Algonquin Power & Utilities (AQN), BlackBerry (BB), Burcon NutraScience (BUROF), First Cobalt (FCC), Canopy Growth (WEED), Alamos Gold (AGI) and Applied Materials (AMAT).

How do I buy shares of Burcon NutraScience?

Shares of BU stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:BU) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -